ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Recursos principais

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
AI Entrar Premium IconPremium Help Menu
Índice Bovespa
124.612,22
-1,13%
S&P 500
6.051,09
0,00%
US Dollar vs BRL
6,0424
0,00%
Bitcoin
101.614,84
0,16%
Brent Oil
74,135
0,00%
As Melhores Corretoras Online
Registration Strip Icon for smarter Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Aclarion Inc (ACONW)

  7. Aclarion Inc (ACONW) Notícias

ACONW

Aclarion (ACONW)

Aclarion Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:ACONW
DataHoraFonteTítuloCódigoCompanhia
02/12/202408:01Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:ACONWAclarion Inc
27/11/202418:03Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ACONWAclarion Inc
22/11/202418:03Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:ACONWAclarion Inc
21/11/202410:00GlobeNewswire Inc.Aclarion Announces Nociscan Featured in RSNA Edition of Siemens MAGNETOM FlashNASDAQ:ACONWAclarion Inc
14/11/202415:03Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ACONWAclarion Inc
13/11/202417:06Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:ACONWAclarion Inc
08/11/202418:18Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:ACONWAclarion Inc
05/11/202402:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:ACONWAclarion Inc
04/11/202408:15Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:ACONWAclarion Inc
25/10/202418:05Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:ACONWAclarion Inc
15/10/202417:00Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:ACONWAclarion Inc
11/10/202417:36Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:ACONWAclarion Inc
10/10/202408:00GlobeNewswire Inc.Aclarion to Participate in the 2024 Maxim Healthcare Virtual SummitNASDAQ:ACONWAclarion Inc
27/09/202407:57GlobeNewswire Inc.Aclarion's Nociscan AI Plays Key Role in Advanced Understanding of Modic ChangesNASDAQ:ACONWAclarion Inc
24/09/202417:54Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:ACONWAclarion Inc
19/09/202418:02Edgar (US Regulatory)Form S-3/A - Registration statement under Securities Act of 1933: [Amend]NASDAQ:ACONWAclarion Inc
12/09/202407:57GlobeNewswire Inc.Aclarion Provides Corporate Update on Nociscan AI Technology MilestonesNASDAQ:ACONWAclarion Inc
10/09/202407:57GlobeNewswire Inc.Aclarion Announces Completion of First Nociscan Exams in LIFEHAB TrialNASDAQ:ACONWAclarion Inc
05/09/202407:57GlobeNewswire Inc.Aclarion Launches Surgeon Partnership to Apply Nociscan’s AI Technology to Personal Injury and Workers Compensation MarketNASDAQ:ACONWAclarion Inc
29/08/202407:57GlobeNewswire Inc.Aclarion Launches Second Clinical Utility and Economic (CLUE) Trial Site With First Surgeon in New JerseyNASDAQ:ACONWAclarion Inc
21/08/202408:57GlobeNewswire Inc.Aclarion Launches the Clinical Utility and Economic (CLUE) Trial to Quantify How Often Nociscan’s AI Generated Biomarker Data Changes Surgical Treatment PlansNASDAQ:ACONWAclarion Inc
15/08/202410:48GlobeNewswire Inc.Aclarion to Present at August 20th Virtual Investor Summit Microcap EventNASDAQ:ACONWAclarion Inc
14/08/202409:08GlobeNewswire Inc.Aclarion Announces First Commercial Agreement in MichiganNASDAQ:ACONWAclarion Inc
13/08/202410:07GlobeNewswire Inc.Aclarion Hits Another Key Milestone by Adding Vitality - Third Major Payer to Cover Nociscan in Greater UKNASDAQ:ACONWAclarion Inc
09/07/202408:00GlobeNewswire Inc.Aclarion Achieves Milestone With Key Second Payer Coverage of Nociscan by Aviva Throughout Greater London, UKNASDAQ:ACONWAclarion Inc
26/06/202409:30GlobeNewswire Inc.Aclarion Announces Initial Payer Coverage of Nociscan by AXA Throughout Greater London, UKNASDAQ:ACONWAclarion Inc
25/06/202409:30GlobeNewswire Inc.Aclarion Expands Commercial Engagement With The London Clinic to Grow Access to Nociscan Throughout Greater LondonNASDAQ:ACONWAclarion Inc
25/04/202410:14GlobeNewswire Inc.Aclarion’s Nociscan Solution to Play Key Role in Groundbreaking LIFEHAB Trial Evaluating the Diagnosis and Treatment of Chronic Low Back PainNASDAQ:ACONWAclarion Inc
04/03/202410:00GlobeNewswire Inc.Aclarion Announces Publication of Compelling Peer-Reviewed Data in International Journal of Spine Surgery Supporting Nociscan as a Gold Standard for Noninvasive Identification of Painful Lumbar DiscsNASDAQ:ACONWAclarion Inc
27/02/202417:22GlobeNewswire Inc.Aclarion Announces Closing of $3.0 Million Public OfferingNASDAQ:ACONWAclarion Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:ACONW

Seu Histórico Recente

BOV
BRKM5
BRASKEM PNA
BOV
IBOV
Índice Bovespa
BOV
PCAR3
PÃO DE AÇUCAR ON
BOV
PRIO3
PETRORIO ON
BOV
AMBP3
Ambipar Participacoes e ... ON
BOV
RCSL4
RECRUSUL PN
BOV
TELB4
TELEBRAS PN
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados